Who Generates Higher Gross Profit? Walgreens Boots Alliance, Inc. or Jazz Pharmaceuticals plc

Walgreens vs. Jazz: A Decade of Gross Profit Comparison

__timestampJazz Pharmaceuticals plcWalgreens Boots Alliance, Inc.
Wednesday, January 1, 2014105545700021569000000
Thursday, January 1, 2015122227700026753000000
Friday, January 1, 2016138258700029874000000
Sunday, January 1, 2017150850500029162000000
Monday, January 1, 2018176937800030792000000
Tuesday, January 1, 2019203383100028159000000
Wednesday, January 1, 2020221465000026077000000
Friday, January 1, 2021265347800028067000000
Saturday, January 1, 2022311885700028266000000
Sunday, January 1, 2023339862700027072000000
Monday, January 1, 202426524000000
Loading chart...

Unlocking the unknown

Walgreens Boots Alliance vs. Jazz Pharmaceuticals: A Gross Profit Showdown

In the competitive landscape of the pharmaceutical and retail sectors, gross profit is a key indicator of financial health and operational efficiency. From 2014 to 2023, Walgreens Boots Alliance, Inc. consistently outperformed Jazz Pharmaceuticals plc in terms of gross profit. Walgreens' gross profit peaked in 2018, reaching approximately $30.8 billion, while Jazz Pharmaceuticals saw its highest gross profit in 2023, with around $3.4 billion. This stark contrast highlights Walgreens' dominance, generating nearly ten times the gross profit of Jazz Pharmaceuticals in their best years. However, Jazz Pharmaceuticals demonstrated a robust growth trajectory, with its gross profit more than tripling over the decade. Despite missing data for 2024, the trend suggests Walgreens maintains a strong lead, but Jazz's growth cannot be overlooked. This analysis underscores the dynamic nature of the industry and the varying scales of operation between these two companies.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
17 Jan 2025